Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D023201:CD40 Ligand / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology / Q000378:metabolism; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000276:immunology / Q000494:pharmacology*; D009206:Myocardium / Q000276:immunology / Q000473:pathology; D010215:Papio; D013552:Swine; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D023201:CD40 Ligand